🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the feasibility and safety of topica...
Status
Unknown
Location
University Hospital Geneva
Start Date
2016-11
Trial ID
NCT02999776
The purpose of this study is to determine whether using Taclonex ointment u...
Status
Terminated
Location
UCSF Psoriasis Skin and Treatment Center
Start Date
2009-06
Trial ID
NCT00924950
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of 4 weeks...
Status
Completed
Location
Center for Dermatology Clinical Research
Start Date
2009-07
Trial ID
NCT00817219
Treatments Being Tested
Evaluation of efficacy and safety of Mapracorat 0.1% ointment and 4 compara...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-11
Trial ID
NCT03399526
This is a phase 1, single centre trial in Japanese healthy male subjects co...
Status
Completed
Location
Investigational site
Start Date
2018-03-20
Trial ID
NCT03476746
Treatments Being Tested
Vasoconstriction study with LEO 90100...
Status
Completed
Location
CPCAD
Start Date
2016-12
Trial ID
NCT02973776
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of microneedle patch ...
Status
Unknown
Location
St. Vincent's Hospital
Start Date
2016-09
Trial ID
NCT02955576
Treatments Being Tested
Patients with psoriasis vulgaris of the trunk and/or limbs are randomised t...
Status
Completed
Location
Universitair Ziekenhuis
Start Date
2005-04
Trial ID
NCT00216892
Treatments Being Tested
Evaluation of safety, pharmacokinetics, and anti-psoriatic efficacy to asse...
Status
Completed
Location
DermResearch, Inc.
Start Date
2016-08
Trial ID
NCT03004339
Comparison of the efficacy of LEO 90100 foam with Dovobet® ointment in the ...
Status
Completed
Location
Leo Pharma Investigational Site
Start Date
2019-01-24
Trial ID
NCT03806790
Treatments Being Tested